Tech Company Financing Transactions
Octave Bioscience Funding Round
Octave Bioscience closed a $32 million Series B funding round on 12/18/2020. Backers included Northpond Ventures, BVF Partners and Casdin Capital.
Transaction Overview
Northpond Ventures (Lead Investor) (Michael Rubin)
Deerfield Capital (Julian Harris)
Echo Health Ventures (Kurt Sheline)
Section 32 (Michael Pellini)
Company Information
Menlo Park, CA 94025
USA
Management Team
Browse more venture capital transactions:
Prev: 12/18/2020: Lyte venture capital transaction
Next: 12/18/2020: Vivace Therapeutics venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs